Delivery Order SPE2DB22D2206-SPE2DB24FHW78

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Injectafer, a 750 mg/15 mL injectable medication. The $2,414.43 firm fixed-price delivery order has a completion date of November 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Injectafer 750 mg/15 ml vials. The $10,756 firm fixed-price contract has a completion date of February 20, 2025 and is not set aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,850.63, is for the delivery of Injectafer 750 mg/15 ml vials. This is a firm fixed-price delivery order contract with a completion date of January 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Injectafer 750 mg/15 ml vial (15 ml) to the Defense Logistics Agency. The $22,558.15 firm fixed-price delivery order has a completion date of June 5, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which provides a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp (DUNS: TGxsdkVQRGhOYUpNR001SFhYREdNdz09) is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $9,456.06. The award is for the pharmaceutical product Injectafer (750 mg/15 ml vial, 15 ml), with an ultimate completion date of November 25, 2024. This IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for the DLA to...
This federal contract award is for the delivery of Injectafer 750 mg/15 ml vial (15 ml) to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $2,110.52. The contract has an ultimate completion date of June 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Injectafer 750 mg/15 ml vials. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $12,803.02 and a performance period through July 2, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $17,086.15, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Injectafer 750 mg/15 ml vials. The contract has a firm fixed price and a completion date of June 18, 2024. Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution giant Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and medical supplies to various federal agencies, particularly the Department of...
This federal contract award is for the delivery of Injectafer 750 mg/15 ml vial medical product to the Defense Logistics Agency (DLA). The $6,929.42 contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 23, 2024, with a completion date of October 24, 2024. The contract is a firm-fixed price delivery order and is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $73,997.38 Delivery Order contract is for the supply of Injectafer 750 mg/15 ml vials. The contract has an ultimate completion date of September 5, 2024. AmerisourceBergen, as a major pharmaceutical distributor, leverages its extensive supply chain to provide a wide range of medications and medical supplies to support various government agencies...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHW78
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Injectafer 750 mg/15 ml vials. The contract has a ceiling value of $7,364.48 and a completion date of June 25, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award for Injectafer vials does not have a set-aside designation, indicating full and open competition. As a leading pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts and support the medical needs of federal agencies, including the Department of Defense and Veterans Affairs healthcare systems.

Generated 9/23/24, 9:52 AM